Pierluigi Paracchi and Stefano Peroncini have joined the Advisory Board of Aurora Fund of Funds. Aurora is a leading tech Fund of Funds platform able to cover global opportunities in multi sector strategies such as ICT, Life Sciences and Deep Tech sectors in the Venture Capital space, combining primary investments, co-investments and secondary transactions.
With more than 20 years of extensive experience in Venture Capital Industry, Deep Tech and FoF, Stefano´s support will help Axon achieve excellence in the deep tech and hardware sectors. Stefano Peroncini, currently CEO of EUREKA! Venture SGR (the first Italian Independent Alternative Investment Fund Manager for deep tech startups), was as well a founding member of Axon in its early days back in 2006 and has been working with Francisco Velázquez and rest of Axon’s team since then in different business developments. He is Member of Investment Committee of FARE Venture (80Ml€ Fund of Funds promoted by regional financial institution Lazio Innova) and previously co-founder and Managing Director of Quantica SGR.
Along with Stefano, Pierluigi Paracchi who is co-founder and Chairman&CEO at Genenta Science (a clinical stage company developing a gene therapy strategy for tumor treatment which has raised €32.1M), has also joined Aurora’s Advisory Board. Pierluigi has +20 years of experience in Life Sciences and ICT, as venture capitalist and board member of some of the most relevant companies in the biotech space and as Founder and CEO of Quantica SGR (i.e. investor and Board Member in the biotech start-up EOS, exited in 2013 for $200M upfront + $220M milestones). He was also a Venture Consultant for Sofinnova Partners and is currently Venture Partner at AAS (EU biotech VC baked by two multinational pharma companies) and co-founder and Board Member at Altheia Science (autoimmune diseases, €17M as Series A). His long track record in healthcare, life sciences and subsectors will most certainly lead to maximizing the benefits for our investors. Pierluigi was also a founding member of Axon back in 2006 and has always been supporting Axon’s developments since then.
Read The Investment Strategy of Aurora Fund Of Funds in the following link